Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review
2006 ◽
Vol 1
(4)
◽
pp. 367-376
◽
2003 ◽
Vol 13
(5)
◽
pp. 289-298
◽
2019 ◽
Vol 117
◽
pp. 107-115
◽